Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing miconazole and white petrolatum and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Miconazole 0.25%/zinc oxide 15%/white petrolatum 81.35% topical ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing white petrolatum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
False |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
False |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
False |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
False |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mineral oil- and white soft paraffin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing salicylic acid and white petrolatum in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing mineral oil and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing salicylic acid and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Miconazole and white soft paraffin and zinc oxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only mineral oil and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only salicylic acid and white petrolatum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mineral oil and white soft paraffin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Salicylic acid and white soft paraffin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paraffin-white soft adverse reaction |
Causative agent (attribute) |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
White soft paraffin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |